nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—lung cancer	0.15	0.512	CbGaD
Alfentanil—ABCB1—lung cancer	0.143	0.488	CbGaD
Alfentanil—ORM1—Gefitinib—lung cancer	0.0663	0.119	CbGbCtD
Alfentanil—ORM1—Erlotinib—lung cancer	0.0392	0.0702	CbGbCtD
Alfentanil—ALB—Gefitinib—lung cancer	0.0279	0.0499	CbGbCtD
Alfentanil—CYP3A5—Gefitinib—lung cancer	0.0224	0.0401	CbGbCtD
Alfentanil—CYP3A5—Teniposide—lung cancer	0.0217	0.0389	CbGbCtD
Alfentanil—ALB—Erlotinib—lung cancer	0.0165	0.0295	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0162	0.029	CbGbCtD
Alfentanil—CYP3A7—Paclitaxel—lung cancer	0.0162	0.029	CbGbCtD
Alfentanil—CYP3A7—Irinotecan—lung cancer	0.016	0.0286	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.016	0.0286	CbGbCtD
Alfentanil—ABCB1—Topotecan—lung cancer	0.016	0.0286	CbGbCtD
Alfentanil—ALB—Irinotecan—lung cancer	0.0149	0.0267	CbGbCtD
Alfentanil—ABCB1—Gefitinib—lung cancer	0.0146	0.0261	CbGbCtD
Alfentanil—CYP3A5—Crizotinib—lung cancer	0.0137	0.0246	CbGbCtD
Alfentanil—CYP3A5—Erlotinib—lung cancer	0.0133	0.0237	CbGbCtD
Alfentanil—CYP3A5—Paclitaxel—lung cancer	0.0121	0.0217	CbGbCtD
Alfentanil—CYP3A5—Irinotecan—lung cancer	0.012	0.0214	CbGbCtD
Alfentanil—CYP3A7—Docetaxel—lung cancer	0.0117	0.0209	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0117	0.0209	CbGbCtD
Alfentanil—ABCB1—Vinorelbine—lung cancer	0.0112	0.0201	CbGbCtD
Alfentanil—CYP3A5—Etoposide—lung cancer	0.00959	0.0172	CbGbCtD
Alfentanil—CYP3A4—Topotecan—lung cancer	0.00956	0.0171	CbGbCtD
Alfentanil—ABCB1—Crizotinib—lung cancer	0.00894	0.016	CbGbCtD
Alfentanil—CYP3A5—Docetaxel—lung cancer	0.00877	0.0157	CbGbCtD
Alfentanil—CYP3A4—Gefitinib—lung cancer	0.00874	0.0157	CbGbCtD
Alfentanil—ABCB1—Gemcitabine—lung cancer	0.00874	0.0156	CbGbCtD
Alfentanil—ABCB1—Erlotinib—lung cancer	0.00863	0.0154	CbGbCtD
Alfentanil—CYP3A4—Teniposide—lung cancer	0.00848	0.0152	CbGbCtD
Alfentanil—ABCB1—Paclitaxel—lung cancer	0.0079	0.0141	CbGbCtD
Alfentanil—ALB—Methotrexate—lung cancer	0.00788	0.0141	CbGbCtD
Alfentanil—ABCB1—Irinotecan—lung cancer	0.00779	0.0139	CbGbCtD
Alfentanil—ABCB1—Vinblastine—lung cancer	0.00693	0.0124	CbGbCtD
Alfentanil—CYP3A4—Vinorelbine—lung cancer	0.00673	0.0121	CbGbCtD
Alfentanil—ABCB1—Cisplatin—lung cancer	0.00635	0.0114	CbGbCtD
Alfentanil—ABCB1—Etoposide—lung cancer	0.00624	0.0112	CbGbCtD
Alfentanil—ABCB1—Docetaxel—lung cancer	0.00571	0.0102	CbGbCtD
Alfentanil—CYP3A4—Crizotinib—lung cancer	0.00536	0.00959	CbGbCtD
Alfentanil—CYP3A4—Erlotinib—lung cancer	0.00517	0.00925	CbGbCtD
Alfentanil—CYP3A4—Paclitaxel—lung cancer	0.00473	0.00847	CbGbCtD
Alfentanil—CYP3A4—Irinotecan—lung cancer	0.00467	0.00836	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—lung cancer	0.00426	0.00762	CbGbCtD
Alfentanil—CYP3A4—Vinblastine—lung cancer	0.00415	0.00743	CbGbCtD
Alfentanil—ABCB1—Methotrexate—lung cancer	0.00412	0.00738	CbGbCtD
Alfentanil—CYP3A4—Etoposide—lung cancer	0.00374	0.00669	CbGbCtD
Alfentanil—CYP3A4—Docetaxel—lung cancer	0.00342	0.00612	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—lung cancer	0.00255	0.00457	CbGbCtD
Alfentanil—Connective tissue disorder—Docetaxel—lung cancer	0.000164	0.00163	CcSEcCtD
Alfentanil—Nervous system disorder—Gemcitabine—lung cancer	0.000164	0.00163	CcSEcCtD
Alfentanil—Skin disorder—Gemcitabine—lung cancer	0.000163	0.00161	CcSEcCtD
Alfentanil—Vision blurred—Paclitaxel—lung cancer	0.000162	0.0016	CcSEcCtD
Alfentanil—Hyperhidrosis—Gemcitabine—lung cancer	0.000162	0.0016	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000162	0.0016	CcSEcCtD
Alfentanil—Visual impairment—Docetaxel—lung cancer	0.000161	0.0016	CcSEcCtD
Alfentanil—Dizziness—Topotecan—lung cancer	0.000161	0.0016	CcSEcCtD
Alfentanil—Hypotension—Irinotecan—lung cancer	0.000161	0.00159	CcSEcCtD
Alfentanil—Vomiting—Vinblastine—lung cancer	0.00016	0.00158	CcSEcCtD
Alfentanil—Dizziness—Erlotinib—lung cancer	0.00016	0.00158	CcSEcCtD
Alfentanil—Agitation—Paclitaxel—lung cancer	0.000158	0.00156	CcSEcCtD
Alfentanil—Headache—Vinblastine—lung cancer	0.000157	0.00156	CcSEcCtD
Alfentanil—Hypotension—Gemcitabine—lung cancer	0.000157	0.00155	CcSEcCtD
Alfentanil—Eye disorder—Docetaxel—lung cancer	0.000156	0.00155	CcSEcCtD
Alfentanil—Anaphylactic shock—Cisplatin—lung cancer	0.000156	0.00155	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000156	0.00154	CcSEcCtD
Alfentanil—Cardiac disorder—Docetaxel—lung cancer	0.000155	0.00154	CcSEcCtD
Alfentanil—Vomiting—Topotecan—lung cancer	0.000155	0.00153	CcSEcCtD
Alfentanil—Loss of consciousness—Etoposide—lung cancer	0.000154	0.00152	CcSEcCtD
Alfentanil—Rash—Topotecan—lung cancer	0.000154	0.00152	CcSEcCtD
Alfentanil—Hypersensitivity—Vinorelbine—lung cancer	0.000154	0.00152	CcSEcCtD
Alfentanil—Dermatitis—Topotecan—lung cancer	0.000154	0.00152	CcSEcCtD
Alfentanil—Vomiting—Erlotinib—lung cancer	0.000153	0.00152	CcSEcCtD
Alfentanil—Nervous system disorder—Cisplatin—lung cancer	0.000153	0.00152	CcSEcCtD
Alfentanil—Cough—Etoposide—lung cancer	0.000153	0.00151	CcSEcCtD
Alfentanil—Somnolence—Irinotecan—lung cancer	0.000153	0.00151	CcSEcCtD
Alfentanil—Headache—Topotecan—lung cancer	0.000153	0.00151	CcSEcCtD
Alfentanil—Tachycardia—Cisplatin—lung cancer	0.000152	0.00151	CcSEcCtD
Alfentanil—Rash—Erlotinib—lung cancer	0.000152	0.00151	CcSEcCtD
Alfentanil—Dermatitis—Erlotinib—lung cancer	0.000152	0.0015	CcSEcCtD
Alfentanil—Convulsion—Etoposide—lung cancer	0.000152	0.0015	CcSEcCtD
Alfentanil—Angiopathy—Docetaxel—lung cancer	0.000152	0.0015	CcSEcCtD
Alfentanil—Skin disorder—Cisplatin—lung cancer	0.000152	0.0015	CcSEcCtD
Alfentanil—Hypertension—Etoposide—lung cancer	0.000151	0.0015	CcSEcCtD
Alfentanil—Immune system disorder—Docetaxel—lung cancer	0.000151	0.0015	CcSEcCtD
Alfentanil—Headache—Erlotinib—lung cancer	0.000151	0.0015	CcSEcCtD
Alfentanil—Loss of consciousness—Paclitaxel—lung cancer	0.000151	0.0015	CcSEcCtD
Alfentanil—Hyperhidrosis—Cisplatin—lung cancer	0.000151	0.00149	CcSEcCtD
Alfentanil—Mediastinal disorder—Docetaxel—lung cancer	0.000151	0.00149	CcSEcCtD
Alfentanil—Chills—Docetaxel—lung cancer	0.00015	0.00149	CcSEcCtD
Alfentanil—Cough—Paclitaxel—lung cancer	0.00015	0.00148	CcSEcCtD
Alfentanil—Asthenia—Vinorelbine—lung cancer	0.00015	0.00148	CcSEcCtD
Alfentanil—Arrhythmia—Docetaxel—lung cancer	0.00015	0.00148	CcSEcCtD
Alfentanil—Nausea—Vinblastine—lung cancer	0.000149	0.00148	CcSEcCtD
Alfentanil—Somnolence—Gemcitabine—lung cancer	0.000149	0.00147	CcSEcCtD
Alfentanil—Convulsion—Paclitaxel—lung cancer	0.000149	0.00147	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Irinotecan—lung cancer	0.000149	0.00147	CcSEcCtD
Alfentanil—Hypertension—Paclitaxel—lung cancer	0.000148	0.00147	CcSEcCtD
Alfentanil—Fatigue—Irinotecan—lung cancer	0.000148	0.00147	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000148	0.00147	CcSEcCtD
Alfentanil—Pruritus—Vinorelbine—lung cancer	0.000148	0.00146	CcSEcCtD
Alfentanil—Pain—Irinotecan—lung cancer	0.000147	0.00146	CcSEcCtD
Alfentanil—Mental disorder—Docetaxel—lung cancer	0.000147	0.00145	CcSEcCtD
Alfentanil—Hypotension—Cisplatin—lung cancer	0.000146	0.00144	CcSEcCtD
Alfentanil—Erythema—Docetaxel—lung cancer	0.000146	0.00144	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000145	0.00144	CcSEcCtD
Alfentanil—Nausea—Topotecan—lung cancer	0.000145	0.00143	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000145	0.00143	CcSEcCtD
Alfentanil—Fatigue—Gemcitabine—lung cancer	0.000144	0.00143	CcSEcCtD
Alfentanil—Confusional state—Etoposide—lung cancer	0.000144	0.00143	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—lung cancer	0.000144	0.00142	CcSEcCtD
Alfentanil—Pain—Gemcitabine—lung cancer	0.000143	0.00142	CcSEcCtD
Alfentanil—Nausea—Erlotinib—lung cancer	0.000143	0.00142	CcSEcCtD
Alfentanil—Anaphylactic shock—Etoposide—lung cancer	0.000143	0.00142	CcSEcCtD
Alfentanil—Feeling abnormal—Irinotecan—lung cancer	0.000142	0.0014	CcSEcCtD
Alfentanil—Confusional state—Paclitaxel—lung cancer	0.000141	0.0014	CcSEcCtD
Alfentanil—Anaphylactic shock—Paclitaxel—lung cancer	0.00014	0.00139	CcSEcCtD
Alfentanil—Tachycardia—Etoposide—lung cancer	0.00014	0.00138	CcSEcCtD
Alfentanil—Skin disorder—Etoposide—lung cancer	0.000139	0.00138	CcSEcCtD
Alfentanil—Hyperhidrosis—Etoposide—lung cancer	0.000138	0.00137	CcSEcCtD
Alfentanil—Feeling abnormal—Gemcitabine—lung cancer	0.000138	0.00137	CcSEcCtD
Alfentanil—Dizziness—Vinorelbine—lung cancer	0.000138	0.00136	CcSEcCtD
Alfentanil—Nervous system disorder—Paclitaxel—lung cancer	0.000138	0.00136	CcSEcCtD
Alfentanil—Tachycardia—Paclitaxel—lung cancer	0.000137	0.00136	CcSEcCtD
Alfentanil—Skin disorder—Paclitaxel—lung cancer	0.000136	0.00135	CcSEcCtD
Alfentanil—Body temperature increased—Irinotecan—lung cancer	0.000136	0.00135	CcSEcCtD
Alfentanil—Hyperhidrosis—Paclitaxel—lung cancer	0.000136	0.00134	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Cisplatin—lung cancer	0.000135	0.00133	CcSEcCtD
Alfentanil—Drowsiness—Methotrexate—lung cancer	0.000134	0.00133	CcSEcCtD
Alfentanil—Hypotension—Etoposide—lung cancer	0.000134	0.00132	CcSEcCtD
Alfentanil—Pain—Cisplatin—lung cancer	0.000134	0.00132	CcSEcCtD
Alfentanil—Vomiting—Vinorelbine—lung cancer	0.000133	0.00131	CcSEcCtD
Alfentanil—Body temperature increased—Gemcitabine—lung cancer	0.000132	0.00131	CcSEcCtD
Alfentanil—Rash—Vinorelbine—lung cancer	0.000132	0.0013	CcSEcCtD
Alfentanil—Dermatitis—Vinorelbine—lung cancer	0.000131	0.0013	CcSEcCtD
Alfentanil—Hypotension—Paclitaxel—lung cancer	0.000131	0.0013	CcSEcCtD
Alfentanil—Headache—Vinorelbine—lung cancer	0.000131	0.00129	CcSEcCtD
Alfentanil—Feeling abnormal—Cisplatin—lung cancer	0.000129	0.00127	CcSEcCtD
Alfentanil—Loss of consciousness—Docetaxel—lung cancer	0.000128	0.00127	CcSEcCtD
Alfentanil—Somnolence—Etoposide—lung cancer	0.000127	0.00126	CcSEcCtD
Alfentanil—Cough—Docetaxel—lung cancer	0.000127	0.00126	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—lung cancer	0.000127	0.00125	CcSEcCtD
Alfentanil—Hypersensitivity—Irinotecan—lung cancer	0.000127	0.00125	CcSEcCtD
Alfentanil—Convulsion—Docetaxel—lung cancer	0.000126	0.00125	CcSEcCtD
Alfentanil—Hypertension—Docetaxel—lung cancer	0.000126	0.00124	CcSEcCtD
Alfentanil—Somnolence—Paclitaxel—lung cancer	0.000125	0.00123	CcSEcCtD
Alfentanil—Nausea—Vinorelbine—lung cancer	0.000124	0.00123	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Etoposide—lung cancer	0.000124	0.00122	CcSEcCtD
Alfentanil—Body temperature increased—Cisplatin—lung cancer	0.000123	0.00122	CcSEcCtD
Alfentanil—Asthenia—Irinotecan—lung cancer	0.000123	0.00122	CcSEcCtD
Alfentanil—Fatigue—Etoposide—lung cancer	0.000123	0.00122	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000123	0.00122	CcSEcCtD
Alfentanil—Pain—Etoposide—lung cancer	0.000122	0.00121	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000121	0.0012	CcSEcCtD
Alfentanil—Fatigue—Paclitaxel—lung cancer	0.000121	0.0012	CcSEcCtD
Alfentanil—Asthenia—Gemcitabine—lung cancer	0.00012	0.00119	CcSEcCtD
Alfentanil—Pain—Paclitaxel—lung cancer	0.00012	0.00119	CcSEcCtD
Alfentanil—Confusional state—Docetaxel—lung cancer	0.00012	0.00119	CcSEcCtD
Alfentanil—Anaphylactic shock—Docetaxel—lung cancer	0.000119	0.00118	CcSEcCtD
Alfentanil—Pruritus—Gemcitabine—lung cancer	0.000119	0.00117	CcSEcCtD
Alfentanil—Feeling abnormal—Etoposide—lung cancer	0.000118	0.00117	CcSEcCtD
Alfentanil—Nervous system disorder—Docetaxel—lung cancer	0.000117	0.00115	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—lung cancer	0.000116	0.00115	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—lung cancer	0.000116	0.00115	CcSEcCtD
Alfentanil—Tachycardia—Docetaxel—lung cancer	0.000116	0.00115	CcSEcCtD
Alfentanil—Feeling abnormal—Paclitaxel—lung cancer	0.000116	0.00114	CcSEcCtD
Alfentanil—Skin disorder—Docetaxel—lung cancer	0.000116	0.00114	CcSEcCtD
Alfentanil—Hypersensitivity—Cisplatin—lung cancer	0.000115	0.00114	CcSEcCtD
Alfentanil—Dizziness—Irinotecan—lung cancer	0.000114	0.00113	CcSEcCtD
Alfentanil—Urticaria—Etoposide—lung cancer	0.000114	0.00112	CcSEcCtD
Alfentanil—Body temperature increased—Etoposide—lung cancer	0.000113	0.00112	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—lung cancer	0.000113	0.00112	CcSEcCtD
Alfentanil—Asthenia—Cisplatin—lung cancer	0.000112	0.00111	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—lung cancer	0.000112	0.00111	CcSEcCtD
Alfentanil—Urticaria—Paclitaxel—lung cancer	0.000111	0.0011	CcSEcCtD
Alfentanil—Hypotension—Docetaxel—lung cancer	0.000111	0.0011	CcSEcCtD
Alfentanil—Body temperature increased—Paclitaxel—lung cancer	0.000111	0.0011	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—lung cancer	0.00011	0.00109	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—lung cancer	0.000109	0.00108	CcSEcCtD
Alfentanil—Vomiting—Irinotecan—lung cancer	0.000109	0.00108	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—lung cancer	0.000109	0.00108	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—lung cancer	0.000109	0.00108	CcSEcCtD
Alfentanil—Rash—Irinotecan—lung cancer	0.000108	0.00107	CcSEcCtD
Alfentanil—Dermatitis—Irinotecan—lung cancer	0.000108	0.00107	CcSEcCtD
Alfentanil—Chills—Methotrexate—lung cancer	0.000108	0.00107	CcSEcCtD
Alfentanil—Headache—Irinotecan—lung cancer	0.000108	0.00107	CcSEcCtD
Alfentanil—Vomiting—Gemcitabine—lung cancer	0.000107	0.00105	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—lung cancer	0.000106	0.00105	CcSEcCtD
Alfentanil—Somnolence—Docetaxel—lung cancer	0.000106	0.00105	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—lung cancer	0.000106	0.00105	CcSEcCtD
Alfentanil—Rash—Gemcitabine—lung cancer	0.000106	0.00105	CcSEcCtD
Alfentanil—Dermatitis—Gemcitabine—lung cancer	0.000106	0.00104	CcSEcCtD
Alfentanil—Hypersensitivity—Etoposide—lung cancer	0.000105	0.00104	CcSEcCtD
Alfentanil—Erythema—Methotrexate—lung cancer	0.000105	0.00104	CcSEcCtD
Alfentanil—Headache—Gemcitabine—lung cancer	0.000105	0.00104	CcSEcCtD
Alfentanil—Hypersensitivity—Paclitaxel—lung cancer	0.000103	0.00102	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Docetaxel—lung cancer	0.000103	0.00102	CcSEcCtD
Alfentanil—Asthenia—Etoposide—lung cancer	0.000103	0.00102	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—lung cancer	0.000103	0.00102	CcSEcCtD
Alfentanil—Fatigue—Docetaxel—lung cancer	0.000103	0.00101	CcSEcCtD
Alfentanil—Nausea—Irinotecan—lung cancer	0.000102	0.00101	CcSEcCtD
Alfentanil—Pain—Docetaxel—lung cancer	0.000102	0.00101	CcSEcCtD
Alfentanil—Pruritus—Etoposide—lung cancer	0.000101	0.001	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—lung cancer	0.000101	0.000996	CcSEcCtD
Alfentanil—Asthenia—Paclitaxel—lung cancer	0.000101	0.000996	CcSEcCtD
Alfentanil—Nausea—Gemcitabine—lung cancer	9.95e-05	0.000985	CcSEcCtD
Alfentanil—Vomiting—Cisplatin—lung cancer	9.93e-05	0.000983	CcSEcCtD
Alfentanil—Pruritus—Paclitaxel—lung cancer	9.93e-05	0.000982	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—lung cancer	9.9e-05	0.000979	CcSEcCtD
Alfentanil—Rash—Cisplatin—lung cancer	9.85e-05	0.000975	CcSEcCtD
Alfentanil—Dermatitis—Cisplatin—lung cancer	9.84e-05	0.000974	CcSEcCtD
Alfentanil—Feeling abnormal—Docetaxel—lung cancer	9.8e-05	0.00097	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—lung cancer	9.76e-05	0.000966	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—lung cancer	9.69e-05	0.000959	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—lung cancer	9.48e-05	0.000938	CcSEcCtD
Alfentanil—Dizziness—Etoposide—lung cancer	9.46e-05	0.000936	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—lung cancer	9.44e-05	0.000934	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—lung cancer	9.41e-05	0.000932	CcSEcCtD
Alfentanil—Body temperature increased—Docetaxel—lung cancer	9.4e-05	0.00093	CcSEcCtD
Alfentanil—Chills—Doxorubicin—lung cancer	9.37e-05	0.000928	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—lung cancer	9.33e-05	0.000923	CcSEcCtD
Alfentanil—Dizziness—Paclitaxel—lung cancer	9.28e-05	0.000918	CcSEcCtD
Alfentanil—Nausea—Cisplatin—lung cancer	9.28e-05	0.000918	CcSEcCtD
Alfentanil—Cough—Methotrexate—lung cancer	9.16e-05	0.000907	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—lung cancer	9.15e-05	0.000906	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—lung cancer	9.1e-05	0.0009	CcSEcCtD
Alfentanil—Vomiting—Etoposide—lung cancer	9.1e-05	0.0009	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—lung cancer	9.09e-05	0.0009	CcSEcCtD
Alfentanil—Rash—Etoposide—lung cancer	9.02e-05	0.000893	CcSEcCtD
Alfentanil—Dermatitis—Etoposide—lung cancer	9.01e-05	0.000892	CcSEcCtD
Alfentanil—Headache—Etoposide—lung cancer	8.96e-05	0.000887	CcSEcCtD
Alfentanil—Vomiting—Paclitaxel—lung cancer	8.92e-05	0.000883	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.88e-05	0.000879	CcSEcCtD
Alfentanil—Rash—Paclitaxel—lung cancer	8.85e-05	0.000875	CcSEcCtD
Alfentanil—Dermatitis—Paclitaxel—lung cancer	8.84e-05	0.000875	CcSEcCtD
Alfentanil—Headache—Paclitaxel—lung cancer	8.79e-05	0.00087	CcSEcCtD
Alfentanil—Hypersensitivity—Docetaxel—lung cancer	8.76e-05	0.000867	CcSEcCtD
Alfentanil—Confusional state—Methotrexate—lung cancer	8.64e-05	0.000855	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—lung cancer	8.57e-05	0.000848	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—lung cancer	8.57e-05	0.000848	CcSEcCtD
Alfentanil—Asthenia—Docetaxel—lung cancer	8.53e-05	0.000844	CcSEcCtD
Alfentanil—Nausea—Etoposide—lung cancer	8.5e-05	0.000841	CcSEcCtD
Alfentanil—Pruritus—Docetaxel—lung cancer	8.41e-05	0.000833	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—lung cancer	8.41e-05	0.000832	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—lung cancer	8.36e-05	0.000827	CcSEcCtD
Alfentanil—Nausea—Paclitaxel—lung cancer	8.33e-05	0.000825	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—lung cancer	8.33e-05	0.000824	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—lung cancer	8.29e-05	0.00082	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—lung cancer	8.01e-05	0.000793	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—lung cancer	7.99e-05	0.000791	CcSEcCtD
Alfentanil—Cough—Doxorubicin—lung cancer	7.94e-05	0.000785	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—lung cancer	7.88e-05	0.00078	CcSEcCtD
Alfentanil—Dizziness—Docetaxel—lung cancer	7.86e-05	0.000778	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—lung cancer	7.85e-05	0.000777	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.69e-05	0.000761	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—lung cancer	7.62e-05	0.000754	CcSEcCtD
Alfentanil—Vomiting—Docetaxel—lung cancer	7.56e-05	0.000748	CcSEcCtD
Alfentanil—Rash—Docetaxel—lung cancer	7.5e-05	0.000742	CcSEcCtD
Alfentanil—Dermatitis—Docetaxel—lung cancer	7.49e-05	0.000741	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—lung cancer	7.48e-05	0.000741	CcSEcCtD
Alfentanil—Headache—Docetaxel—lung cancer	7.45e-05	0.000737	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—lung cancer	7.42e-05	0.000734	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—lung cancer	7.4e-05	0.000732	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—lung cancer	7.39e-05	0.000731	CcSEcCtD
Alfentanil—Pain—Methotrexate—lung cancer	7.33e-05	0.000725	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—lung cancer	7.28e-05	0.00072	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—lung cancer	7.24e-05	0.000717	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—lung cancer	7.21e-05	0.000713	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—lung cancer	7.17e-05	0.00071	CcSEcCtD
Alfentanil—Nausea—Docetaxel—lung cancer	7.06e-05	0.000699	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—lung cancer	7.06e-05	0.000699	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—lung cancer	6.93e-05	0.000686	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—lung cancer	6.81e-05	0.000674	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—lung cancer	6.78e-05	0.00067	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—lung cancer	6.6e-05	0.000653	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—lung cancer	6.41e-05	0.000634	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—lung cancer	6.4e-05	0.000633	CcSEcCtD
Alfentanil—Pain—Doxorubicin—lung cancer	6.35e-05	0.000628	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—lung cancer	6.31e-05	0.000625	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—lung cancer	6.15e-05	0.000609	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—lung cancer	6.12e-05	0.000605	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—lung cancer	6.06e-05	0.0006	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—lung cancer	5.9e-05	0.000583	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—lung cancer	5.87e-05	0.000581	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—lung cancer	5.67e-05	0.000561	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—lung cancer	5.47e-05	0.000541	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—lung cancer	5.45e-05	0.000539	CcSEcCtD
Alfentanil—Rash—Methotrexate—lung cancer	5.4e-05	0.000535	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—lung cancer	5.4e-05	0.000534	CcSEcCtD
Alfentanil—Headache—Methotrexate—lung cancer	5.37e-05	0.000531	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—lung cancer	5.32e-05	0.000527	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—lung cancer	5.25e-05	0.00052	CcSEcCtD
Alfentanil—Nausea—Methotrexate—lung cancer	5.09e-05	0.000504	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—lung cancer	4.91e-05	0.000486	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—lung cancer	4.72e-05	0.000467	CcSEcCtD
Alfentanil—Rash—Doxorubicin—lung cancer	4.68e-05	0.000463	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—lung cancer	4.68e-05	0.000463	CcSEcCtD
Alfentanil—Headache—Doxorubicin—lung cancer	4.65e-05	0.00046	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—lung cancer	4.41e-05	0.000436	CcSEcCtD
Alfentanil—CYP3A4—Metabolism—CKB—lung cancer	9.57e-06	0.000202	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—UGT1A1—lung cancer	9.41e-06	0.000198	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.41e-06	0.000198	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AVP—lung cancer	9.37e-06	0.000197	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	9.36e-06	0.000197	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	9.34e-06	0.000197	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB1—lung cancer	9.33e-06	0.000197	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCG2—lung cancer	9.31e-06	0.000196	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADCY1—lung cancer	9.31e-06	0.000196	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	9.22e-06	0.000194	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—TYMS—lung cancer	9.17e-06	0.000193	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ENO2—lung cancer	9.13e-06	0.000192	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HPGDS—lung cancer	9.13e-06	0.000192	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CD—lung cancer	9.08e-06	0.000191	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPP2R1B—lung cancer	9.07e-06	0.000191	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GNG11—lung cancer	9.07e-06	0.000191	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—lung cancer	9.06e-06	0.000191	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1R—lung cancer	9.02e-06	0.00019	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM2—lung cancer	9e-06	0.00019	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CNDP2—lung cancer	9e-06	0.00019	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	8.98e-06	0.000189	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.95e-06	0.000189	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	8.92e-06	0.000188	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HES1—lung cancer	8.86e-06	0.000187	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTT1—lung cancer	8.86e-06	0.000187	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GCLC—lung cancer	8.75e-06	0.000184	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2A6—lung cancer	8.75e-06	0.000184	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTMR3—lung cancer	8.75e-06	0.000184	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.72e-06	0.000184	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—RAF1—lung cancer	8.69e-06	0.000183	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2E1—lung cancer	8.64e-06	0.000182	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDOA—lung cancer	8.64e-06	0.000182	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP1A1—lung cancer	8.59e-06	0.000181	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	8.58e-06	0.000181	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—IL2—lung cancer	8.58e-06	0.000181	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NQO1—lung cancer	8.55e-06	0.00018	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PGAM1—lung cancer	8.53e-06	0.00018	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ERCC2—lung cancer	8.52e-06	0.00018	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	8.49e-06	0.000179	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NCOA3—lung cancer	8.39e-06	0.000177	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ENO1—lung cancer	8.3e-06	0.000175	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	8.29e-06	0.000175	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.27e-06	0.000174	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ABCG2—lung cancer	8.16e-06	0.000172	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADCY1—lung cancer	8.16e-06	0.000172	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL8—lung cancer	8.15e-06	0.000172	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2A7—lung cancer	8.14e-06	0.000171	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RAF1—lung cancer	8.11e-06	0.000171	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB3—lung cancer	8.1e-06	0.000171	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ENO2—lung cancer	8e-06	0.000169	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HPGDS—lung cancer	8e-06	0.000169	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SDC4—lung cancer	7.96e-06	0.000168	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPP2R1B—lung cancer	7.95e-06	0.000168	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CB—lung cancer	7.92e-06	0.000167	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL2—lung cancer	7.79e-06	0.000164	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TERT—lung cancer	7.76e-06	0.000164	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTT1—lung cancer	7.76e-06	0.000164	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—STK11—lung cancer	7.7e-06	0.000162	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2A6—lung cancer	7.67e-06	0.000162	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GCLC—lung cancer	7.67e-06	0.000162	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	7.65e-06	0.000161	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGFR1—lung cancer	7.54e-06	0.000159	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	7.53e-06	0.000159	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2E1—lung cancer	7.44e-06	0.000157	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIF1A—lung cancer	7.43e-06	0.000156	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—APOA1—lung cancer	7.37e-06	0.000155	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NQO1—lung cancer	7.36e-06	0.000155	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ENO1—lung cancer	7.27e-06	0.000153	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IL2—lung cancer	7.27e-06	0.000153	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	7.27e-06	0.000153	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—RRM1—lung cancer	7.25e-06	0.000153	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA3—lung cancer	7.25e-06	0.000153	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.21e-06	0.000152	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APOA1—lung cancer	7.17e-06	0.000151	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.14e-06	0.00015	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—lung cancer	7.13e-06	0.00015	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KDR—lung cancer	7.1e-06	0.00015	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.02e-06	0.000148	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAT—lung cancer	6.94e-06	0.000146	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—B4GALT5—lung cancer	6.82e-06	0.000144	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	6.8e-06	0.000143	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB1—lung cancer	6.75e-06	0.000142	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CG—lung cancer	6.73e-06	0.000142	CbGpPWpGaD
Alfentanil—ALB—Metabolism—STK11—lung cancer	6.63e-06	0.00014	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA4—lung cancer	6.63e-06	0.00014	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—TYMS—lung cancer	6.63e-06	0.00014	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—lung cancer	6.55e-06	0.000138	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KIT—lung cancer	6.54e-06	0.000138	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APC—lung cancer	6.54e-06	0.000138	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CG—lung cancer	6.54e-06	0.000138	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—NRAS—lung cancer	6.54e-06	0.000138	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—EP300—lung cancer	6.52e-06	0.000137	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2E1—lung cancer	6.52e-06	0.000137	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGF—lung cancer	6.47e-06	0.000136	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA2—lung cancer	6.46e-06	0.000136	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NQO1—lung cancer	6.45e-06	0.000136	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—POMC—lung cancer	6.41e-06	0.000135	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SRC—lung cancer	6.34e-06	0.000134	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK3—lung cancer	6.27e-06	0.000132	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CREBBP—lung cancer	6.24e-06	0.000131	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA1—lung cancer	6.24e-06	0.000131	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.23e-06	0.000131	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—POMC—lung cancer	6.23e-06	0.000131	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1A1—lung cancer	6.21e-06	0.000131	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—lung cancer	6.18e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCC3—lung cancer	6.17e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ERCC2—lung cancer	6.16e-06	0.00013	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.15e-06	0.00013	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BRAF—lung cancer	6.15e-06	0.00013	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—lung cancer	6.14e-06	0.000129	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NRAS—lung cancer	6.1e-06	0.000129	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6R—lung cancer	6.07e-06	0.000128	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CREBBP—lung cancer	6.07e-06	0.000128	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAT—lung cancer	5.97e-06	0.000126	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKR1C1—lung cancer	5.97e-06	0.000126	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EGFR—lung cancer	5.96e-06	0.000126	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.94e-06	0.000125	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CD—lung cancer	5.92e-06	0.000125	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK3—lung cancer	5.85e-06	0.000123	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—lung cancer	5.84e-06	0.000123	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—STK11—lung cancer	5.81e-06	0.000122	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB1—lung cancer	5.81e-06	0.000122	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UGT1A1—lung cancer	5.8e-06	0.000122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAP2K1—lung cancer	5.79e-06	0.000122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CD—lung cancer	5.75e-06	0.000121	CbGpPWpGaD
Alfentanil—ALB—Metabolism—TYMS—lung cancer	5.71e-06	0.00012	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	5.7e-06	0.00012	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—lung cancer	5.64e-06	0.000119	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—KRAS—lung cancer	5.63e-06	0.000119	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GNG11—lung cancer	5.59e-06	0.000118	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—lung cancer	5.38e-06	0.000113	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1A1—lung cancer	5.35e-06	0.000113	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—APOA1—lung cancer	5.33e-06	0.000112	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDOA—lung cancer	5.32e-06	0.000112	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ERCC2—lung cancer	5.3e-06	0.000112	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KRAS—lung cancer	5.25e-06	0.000111	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAT—lung cancer	5.23e-06	0.00011	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	5.17e-06	0.000109	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NCOA3—lung cancer	5.17e-06	0.000109	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CB—lung cancer	5.16e-06	0.000109	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MDM2—lung cancer	5.15e-06	0.000109	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RAF1—lung cancer	5.13e-06	0.000108	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—lung cancer	5.11e-06	0.000108	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB2—lung cancer	5.08e-06	0.000107	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCG2—lung cancer	5.03e-06	0.000106	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADCY1—lung cancer	5.03e-06	0.000106	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CB—lung cancer	5.01e-06	0.000106	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MTOR—lung cancer	5.01e-06	0.000106	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—TYMS—lung cancer	5e-06	0.000105	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—lung cancer	4.94e-06	0.000104	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HPGDS—lung cancer	4.93e-06	0.000104	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ENO2—lung cancer	4.93e-06	0.000104	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.9e-06	0.000103	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CG—lung cancer	4.86e-06	0.000102	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—lung cancer	4.83e-06	0.000102	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL8—lung cancer	4.82e-06	0.000101	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HRAS—lung cancer	4.79e-06	0.000101	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTT1—lung cancer	4.78e-06	0.000101	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GCLC—lung cancer	4.73e-06	9.96e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2A6—lung cancer	4.73e-06	9.96e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1A1—lung cancer	4.69e-06	9.87e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—lung cancer	4.67e-06	9.84e-05	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—lung cancer	4.65e-06	9.81e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ERCC2—lung cancer	4.65e-06	9.79e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—POMC—lung cancer	4.63e-06	9.76e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—lung cancer	4.61e-06	9.71e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL2—lung cancer	4.6e-06	9.7e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—APOA1—lung cancer	4.59e-06	9.67e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—lung cancer	4.58e-06	9.65e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CREBBP—lung cancer	4.51e-06	9.5e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCND1—lung cancer	4.49e-06	9.46e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ENO1—lung cancer	4.48e-06	9.44e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUN—lung cancer	4.48e-06	9.44e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HRAS—lung cancer	4.47e-06	9.41e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTEN—lung cancer	4.46e-06	9.39e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.39e-06	9.26e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—lung cancer	4.36e-06	9.18e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1A—lung cancer	4.34e-06	9.15e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTEN—lung cancer	4.33e-06	9.13e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CD—lung cancer	4.28e-06	9.01e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—EP300—lung cancer	4.25e-06	8.95e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—lung cancer	4.23e-06	8.9e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—lung cancer	4.22e-06	8.89e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CG—lung cancer	4.19e-06	8.83e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EP300—lung cancer	4.13e-06	8.7e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—APOA1—lung cancer	4.02e-06	8.47e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2E1—lung cancer	4.02e-06	8.47e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SRC—lung cancer	4.02e-06	8.46e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—POMC—lung cancer	3.99e-06	8.4e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NQO1—lung cancer	3.97e-06	8.37e-05	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—lung cancer	3.94e-06	8.31e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—lung cancer	3.91e-06	8.24e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CREBBP—lung cancer	3.88e-06	8.18e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—lung cancer	3.87e-06	8.16e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NRAS—lung cancer	3.86e-06	8.14e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CB—lung cancer	3.73e-06	7.85e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK3—lung cancer	3.7e-06	7.8e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—lung cancer	3.69e-06	7.78e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CD—lung cancer	3.68e-06	7.76e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CG—lung cancer	3.67e-06	7.73e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—lung cancer	3.6e-06	7.58e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—STK11—lung cancer	3.58e-06	7.55e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGFR—lung cancer	3.52e-06	7.42e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—POMC—lung cancer	3.49e-06	7.36e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CREBBP—lung cancer	3.4e-06	7.17e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KRAS—lung cancer	3.33e-06	7.01e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—lung cancer	3.31e-06	6.98e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CD—lung cancer	3.23e-06	6.8e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAT—lung cancer	3.22e-06	6.79e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTEN—lung cancer	3.22e-06	6.79e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CB—lung cancer	3.21e-06	6.76e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—lung cancer	3.19e-06	6.71e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—lung cancer	3.18e-06	6.7e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—lung cancer	3.14e-06	6.62e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB1—lung cancer	3.14e-06	6.61e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TYMS—lung cancer	3.08e-06	6.49e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—EP300—lung cancer	3.07e-06	6.47e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—lung cancer	3.06e-06	6.44e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—lung cancer	3.05e-06	6.42e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—lung cancer	2.96e-06	6.23e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1A1—lung cancer	2.89e-06	6.08e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ERCC2—lung cancer	2.86e-06	6.03e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HRAS—lung cancer	2.83e-06	5.96e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CB—lung cancer	2.81e-06	5.93e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—lung cancer	2.79e-06	5.87e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTEN—lung cancer	2.77e-06	5.84e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—lung cancer	2.71e-06	5.7e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—EP300—lung cancer	2.65e-06	5.57e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—lung cancer	2.57e-06	5.41e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—lung cancer	2.5e-06	5.26e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—APOA1—lung cancer	2.48e-06	5.22e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTEN—lung cancer	2.43e-06	5.12e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—EP300—lung cancer	2.32e-06	4.88e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—lung cancer	2.27e-06	4.79e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CG—lung cancer	2.26e-06	4.76e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—POMC—lung cancer	2.15e-06	4.54e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CREBBP—lung cancer	2.1e-06	4.42e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CD—lung cancer	1.99e-06	4.19e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—lung cancer	1.96e-06	4.13e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—lung cancer	1.96e-06	4.12e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—lung cancer	1.86e-06	3.91e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CB—lung cancer	1.73e-06	3.65e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—lung cancer	1.72e-06	3.62e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—lung cancer	1.71e-06	3.61e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—lung cancer	1.6e-06	3.37e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTEN—lung cancer	1.5e-06	3.15e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—EP300—lung cancer	1.43e-06	3.01e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—lung cancer	1.4e-06	2.95e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—lung cancer	1.06e-06	2.23e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—lung cancer	8.63e-07	1.82e-05	CbGpPWpGaD
